Triangle Insights Group - Crunchbase Company Profile & Funding

Overview

Triangle Insights Group

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Triangle Insights Group

CB Rank

398005

Triangle Insights Group is a management consulting firm.

Acquired by

Mercalis

Founded

obfuscation

Private

Boston, Massachusetts, United States

11-50

triangleinsightsgroup.com/

Life Science

Management Consulting

Pharmaceutical

Details

Legal Name

Triangle Insights Group, LLC.

Operating Status

Active

Company Type

For Profit

About the Company

Triangle Insights Group, LLC is a strategy consulting firm guiding on the most critical business issues to leaders in life sciences organizations. The firm’s approach combines a deep knowledge of the industry, across therapeutic areas and functional groups, with a dedication to creativity and strong critical thinking. Recommendations from

Triangle Insights Group are original, relevant to the industry environment, and supported by rigorous analytics.

Phone Number

+1(919) 813 6100

Contact Email

contactus@triangleinsights.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Brand Strategy and Commercialization

Provides strategic guidance and execution support for life science brands, including positioning, segmentation, competitive strategy, forecasting, and launch planning.

Corporate Strategy & Due Diligence

Supports pharmaceutical companies and investors with commercial assessments, portfolio strategy, opportunity identification, and transaction due diligence.